Advertisements



We are Sorry, This Page doesn't Exist


Shekhar Gupta: Judge thyself too, Your Lordships

The judiciary is under threat from within - from stretching jurisdictions, headline-hunting and its inability to put its own house in order.....»»

Category: topSource: business-standardApr 20th, 2018

Shekhar Gupta: When spies plot peace

Some untold or barely told stories of Indian and Pakistani spymasters making peace on the sidelines of war.....»»

Category: topSource: business-standardMay 25th, 2018

Shekhar Gupta: Because Modiji says so

He's our most polarising leader, deeply hated by many but equally loved by more, especially the young. To extrapolate BJP's struggles in Gujarat and Karnataka to 2019 is being fatally complacent.....»»

Category: topSource: business-standardMay 18th, 2018

Shekhar Gupta: Return of the BJP"s "Iron Men"

Come to Ballari to see the BJP's starkest compromise with organised political crime and corruption yet because of its desperation to win Karnataka.....»»

Category: topSource: business-standardMay 11th, 2018

Shekhar Gupta: Dressing up military history in fatigues

Over the decades, a spiced up, hyper-nationalist version of military history has been built: That politicians wronged the generals. No wonder PM Modi got his facts all mixed up.....»»

Category: topSource: business-standardMay 4th, 2018

Shekhar Gupta: Because freedom can"t be salami-sliced

The media can disagree, fight and judge itself. But it can survive and thrive only by closing ranks when its freedoms are under attack.....»»

Category: topSource: business-standardApr 13th, 2018

Shekhar Gupta: Cracks in the Hindu consensus

BJP overpowered caste divisions to sweep 2014. But the Dalits are angry and the divides are back in play, spelling trouble for the party in 2019.....»»

Category: topSource: business-standardApr 6th, 2018

Biohaven allowed to proceed with BHV-3241 Phase 3 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall2 hr. 44 min. ago

Bayer requests that CA judge limit evidence in Roundup trial, Reuters says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 44 min. ago

Bayer asks California judge to limit evidence in another Roundup cancer trial

Ba.....»»

Category: topSource: reuters11 hr. 44 min. ago

NeuroMetrix reports publication of randomized controlled trial of Quell

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall19 hr. 44 min. ago

Aurinia drops after Phase 2 trial results fail to meet primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall21 hr. 59 min. ago

Ultragenyx: Patient deaths in UX007 trial deemed related to disease progression

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Ultragenyx reports reductions in major clinical events sustained in UX007 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Veru initiates Phase 1b/2 clinical trial for VERU-1111

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Incyte treats first patient in Phase 3 clinical trial of itacitinib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Aurinia"s Dry Eye Syndrome Drug Produces Mixed Results In Mid-Stage Trial

Small-cap biotech Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) fell Tuesday morning following the release of clinical trial results. read more.....»»

Category: blogSource: benzingaJan 22nd, 2019

Medtronic stock falls 0.5% after disappointing angioplasty trial data

Shares of Dublin-based Medtronic Plc fell 0.5% in premarket trade Tuesday morning after the company announced its paclitaxel-coated balloon for angiopl.....»»

Category: topSource: marketwatchJan 22nd, 2019

Ultragenyx stock up 2.9% after safety and efficacy trial reaffirms Phase 2 data

Shares of Ultragenyx Pharmaceutical Inc. rose 2.9% in premarket trade Tuesday after the company announced positive results from a safety and efficacy study looking at a treatment for patients with lo.....»»

Category: topSource: marketwatchJan 22nd, 2019

Aurinia Pharmaceuticals drops 11% to $6.70 after dry-eye trial results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019